| Autor: |
Strickland SV; Departments of Pathology (S.V.S, M.H.R., R.L.G., M.R.K.) Obstetrics and Gynecology, Division of Gynecologic Oncology (B.S.N., K.P.P.), University of Washington, Seattle, Washington., Rendi MH, Garcia RL, Norquist BS, Pennington KP, Kilgore MR |
| Jazyk: |
angličtina |
| Zdroj: |
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists [Int J Gynecol Pathol] 2018 Sep; Vol. 37 (5), pp. 414-420. |
| DOI: |
10.1097/PGP.0000000000000445 |
| Abstrakt: |
Intraoperative assessment (IA) of uteri is often used to help determine whether to perform lymphadenectomy in patients with endometrial carcinoma. We sought to perform a quality assurance review of the practice of IA at our institution. In a 1-yr period, 107 hysterectomies had an IA performed. Grade of neoplasm in preoperative endometrial biopsy, neoplasm size, depth of myometrial invasion at IA, operative management, and final histologic features were recorded. Operative reports were reviewed to assess the surgeon's interpretation of the IA and the effect on surgical management. The sensitivity and specificity for IA of deep myometrial invasion (>50% myometrial thickness) compared with final histology was 76.9% and 91.1%. The positive predictive value was 71.4%, negative predictive value 93.2% and accuracy 88%. Neoplasm size was provided in 47% of cases. In 10% of patients lymphadenectomy was performed despite low-risk features. IA results were included in the operative report in 87% of cases. There were differences in 8.4% of cases between the IA diagnosis and the surgeon's operative report. IA of deep myometrial invasion is reliable at our institution. Several metrics for quality improvement have been identified as a result of this retrospective review. These include but are not limited to more reliable reporting of neoplasm size, documentation, and communication with gynecologic oncologists. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
